Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
Views & Analysis Medical affairs: learning to change behaviour? Research points to the need for greater engagement with behavioural science among medical affairs professionals.
Views & Analysis Medical affairs: leading a transformation in medicines Medical Affairs is leading the change towards a more patient and customer-centric, data driven industry.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.